Glycolytic metabolism of CD8 + T‐cells affects susceptibility to human leukocyte antigen‐mediated abacavir‐induced hypersensitivity
British Journal of Pharmacology · 2026
DOI: 10.1111/bph.70385 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Takeshi Susukida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Biology and Immunology, Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama, Toyama, Japan. Hauptthemen laut MEDLINE: Dideoxynucleosides, Drug Hypersensitivity, CD8-Positive T-Lymphocytes, HLA-B Antigens. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Nakatomi Foundation, Tamura Science and Technology Foundation.
Abstract (Originalsprache)
Background and Purpose Drug hypersensitivity reactions (DHRs) associated with a specific human leukocyte antigen (HLA) allotype do not manifest uniformly in all individuals within an HLA model population. This scenario highlights the complexity of predicting drug hypersensitivity reaction risk without considering additional factors. Furthermore, conducting prospective clinical studies of drug hypersensitivity reactions in humans is unfeasible. Therefore, this study aimed to prospectively evaluate HLA‐mediated drug hypersensitivity reactions by using a unique transgenic mouse line harbouring HLA‐B*57:01 (B*57:01‐Tg) and performing abacavir‐induced hypersensitivity reactions. Experimental Approach B*57:01‐Tg mice or their littermates were orally administered either an abacavir‐containing or a vehicle‐only diet. Subsequently, analyses were performed on isolated CD8 + T‐cells collected from the lymph nodes, ear biopsies, or plasma of these mice. Key Results RNA sequencing and proteomic data analyses performed on the isolated CD8 + T‐cells demonstrated that the expression levels of several glycolytic enzymes, including hexokinase 2, were significantly up‐regulated in abacavir‐treated B*57:01‐Tg mice. Moreover, the glycolytic rate and metabolite production significantly increased in these mice. Although treatment with the pyruvic acid carrier inhibitor UK5099 did not affect CD8 + T‐cell activation, inhibiting glycolysis using 2‐deoxy‐D‐glucose or diet‐based calorie restriction attenuated the increase in IFN‐γ–secreting effector memory CD8 + T‐cells. Consequently, this attenuation prevented CD8 + T‐cell dermal infiltration in abacavir‐treated B*57:01‐Tg mice. Conclusion and Implications Overall, these results suggest the indispensable role of glycolytic CD8 + T‐cell metabolism in HLA‐mediated abacavir‐induced hypersensitivity reactions, which may further determine susceptibility to HLA‐mediated drug hypersensitivity reactions in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cancer Biology and Immunology, Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama, Toyama, Japan.
- Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.
- Divisions of Clinical Pharmacokinetics, Department of Pharmaceutical Sciences, International University of Health and Welfare, Otawara, Tochigi, Japan.
- Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan.
- Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Chiba, Japan.
ORCID-Profile: Takeshi Susukida, Yuchen Sun
Förderung
- Japan Society for the Promotion of Science
- Nakatomi Foundation
- Tamura Science and Technology Foundation
- 2024 Director Leadership Expenses, Institute of Natural Medicine, University of Toyama
Zitieren
APA
Susukida, T., Sun, Y., Arakawa, N., Hirao, T., Mizuno, T., Aoki, S., Ito, K., & Hayakawa, Y. (2026). Glycolytic metabolism of CD8 + T‐cells affects susceptibility to human leukocyte antigen‐mediated abacavir‐induced hypersensitivity. British Journal of Pharmacology. https://doi.org/10.1111/bph.70385
Vancouver
Susukida T, Sun Y, Arakawa N, Hirao T, Mizuno T, Aoki S, et al. Glycolytic metabolism of CD8 + T‐cells affects susceptibility to human leukocyte antigen‐mediated abacavir‐induced hypersensitivity. British Journal of Pharmacology. 2026. doi:10.1111/bph.70385
BibTeX
@article{Susukida2026,
author = {Susukida, Takeshi and Sun, Yuchen and Arakawa, Noriaki and Hirao, Takuya and Mizuno, Tadahaya and Aoki, Shigeki and Ito, Kousei and Hayakawa, Yoshihiro},
title = {Glycolytic metabolism of CD8 + T‐cells affects susceptibility to human leukocyte antigen‐mediated abacavir‐induced hypersensitivity},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70385}
}
EUVIMED